6 results on '"Dai, Rudin Z. W."'
Search Results
2. Disease Burden of Clostridium difficile Infections in Adults, Hong Kong, China, 2006-2014.
- Author
-
Ho, Jeffery, Dai, Rudin Z. W., Kwong, Thomas N. Y., Xiansong Wang, Lin Zhang, Ip, Margaret, Chan, Raphael, Hawkey, Peter M. K., Lam, Kelvin L. Y., Wong, Martin C. S., Tse, Gary, Chan, Matthew T. V., Chan, Francis K. L., Jun Yu, Siew C. Ng, Lee, Nelson, Wu, Justin C. Y., Sung, Joseph J. Y., Wu, William K. K., and Wong, Sunny H.
- Subjects
- *
CLOSTRIDIUM diseases , *CLOSTRIDIOIDES difficile , *DISEASE incidence , *OLDER people , *DISEASES in older people , *COMPARATIVE studies , *CROSS infection , *EPIDEMIOLOGY , *RESEARCH methodology , *MEDICAL cooperation , *RESEARCH , *SURVIVAL analysis (Biometry) , *DISEASE relapse , *EVALUATION research , *COMMUNITY-acquired infections , *CROSS-sectional method - Abstract
Cross-sectional studies suggest an increasing trend in incidence and relatively low recurrence rates of Clostridium difficile infections in Asia than in Europe and North America. The temporal trend of C. difficile infection in Asia is not completely understood. We conducted a territory-wide population-based observational study to investigate the burden and clinical outcomes in Hong Kong, China, over a 9-year period. A total of 15,753 cases were identified, including 14,402 (91.4%) healthcare-associated cases and 817 (5.1%) community-associated cases. After adjustment for diagnostic test, we found that incidence increased from 15.41 cases/100,000 persons in 2006 to 36.31 cases/100,000 persons in 2014, an annual increase of 26%. This increase was associated with elderly patients, for whom incidence increased 3-fold over the period. Recurrence at 60 days increased from 5.7% in 2006 to 9.1% in 2014 (p<0.001). Our data suggest the need for further surveillance, especially in Asia, which contains ≈60% of the world's population. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
3. Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia.
- Author
-
Wong, Sunny H., Kwong, Thomas N. Y., Tai-Cheong Chow, Luk, Arthur K. C., Dai, Rudin Z. W., Geicho Nakatsu, Lam, Thomas Y. T., Lin Zhang, Wu, Justin C. Y., Chan, Francis K. L., Ng, Simon S. M., Wong, Martin C. S., Siew C. Ng, Wu, William K. K., Yu, Jun, and Sung, Joseph J. Y.
- Subjects
FUSOBACTERIUM ,BACTEROIDACEAE ,IMMUNOCHEMISTRY ,FECAL analysis ,COLON cancer - Published
- 2017
- Full Text
- View/download PDF
4. Oncogenes without a Neighboring Tumor-Suppressor Gene Are More Prone to Amplification.
- Author
-
Wu, William K. K., Xiangchun Li, Xiansong Wang, Dai, Rudin Z. W., Cheng, Alfred S. L., Wang, Maggie H. T., Kwong, Thomas, Chow, Tai C., Jun Yu, Chan, Matthew T. V., and Wong, Sunny H.
- Abstract
Focal copy number gains or losses are important genomic hallmarks of cancer. The genomic distribution of oncogenes and tumor-suppressor genes (TSG) in relation to focal copy number aberrations is unclear. Our analysis revealed that the mean distance of TSGs from oncogenes was significantly shorter than that of noncancer genes, suggesting that oncogenes and TSGs tend to be in close physical proximity in the human genome. Such relationship was conserved in mouse and drosophila. Pan-cancer analysis using data from The Cancer Genome Atlas indicated that oncogenes without a nearby TSG are more prone to amplification. In conclusion, our study provides evidence for the nonrandom distribution of oncogenes and TSGs across different species. Our data also support that the existence of a neighboring TSG can suppress amplification of an oncogene, shedding new light on a previously unappreciated protective mechanism of TSGs. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
5. Quantitation of faecal Fusobacteriumimproves faecal immunochemical test in detecting advanced colorectal neoplasia
- Author
-
Wong, Sunny H, Kwong, Thomas N Y, Chow, Tai-Cheong, Luk, Arthur K C, Dai, Rudin Z W, Nakatsu, Geicho, Lam, Thomas Y T, Zhang, Lin, Wu, Justin C Y, Chan, Francis K L, Ng, Simon S M, Wong, Martin C S, Ng, Siew C, Wu, William K K, Yu, Jun, and Sung, Joseph J Y
- Abstract
ObjectiveThere is a need for an improved biomarker for colorectal cancer (CRC) and advanced adenoma. We evaluated faecal microbial markers for clinical use in detecting CRC and advanced adenoma.DesignWe measured relative abundance of Fusobacterium nucleatum(Fn), Peptostreptococcus anaerobius(Pa) and Parvimonas micra(Pm) by quantitative PCR in 309 subjects, including 104 patients with CRC, 103 patients with advanced adenoma and 102 controls. We evaluated the diagnostic performance of these biomarkers with respect to faecal immunochemical test (FIT), and validated the results in an independent cohort of 181 subjects.ResultsThe abundance was higher for all three individual markers in patients with CRC than controls (p<0.001), and for marker Fnin patients with advanced adenoma than controls (p=0.022). The marker Fn, when combined with FIT, showed superior sensitivity (92.3% vs 73.1%, p<0.001) and area under the receiver-operating characteristic curve (AUC) (0.95 vs 0.86, p<0.001) than stand-alone FIT in detecting CRC in the same patient cohort. This combined test also increased the sensitivity (38.6% vs 15.5%, p<0.001) and AUC (0.65 vs 0.57, p=0.007) for detecting advanced adenoma. The performance gain for both CRC and advanced adenoma was confirmed in the validation cohort (p=0.0014 and p=0.031, respectively).ConclusionsThis study identified marker Fnas a valuable marker to improve diagnostic performance of FIT, providing a complementary role to detect lesions missed by FIT alone. This simple approach may improve the clinical utility of the current FIT, and takes one step further towards a non-invasive, potentially more accurate and affordable diagnosis of advanced colorectal neoplasia.
- Published
- 2017
- Full Text
- View/download PDF
6. Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.
- Author
-
Kwong TNY, Wang X, Nakatsu G, Chow TC, Tipoe T, Dai RZW, Tsoi KKK, Wong MCS, Tse G, Chan MTV, Chan FKL, Ng SC, Wu JCY, Wu WKK, Yu J, Sung JJY, and Wong SH
- Subjects
- Adult, Aged, Aged, 80 and over, Bacteroides fragilis isolation & purification, Bacteroides fragilis pathogenicity, Biopsy, Carcinogenesis, Colon pathology, Colorectal Neoplasms diagnosis, Colorectal Neoplasms epidemiology, Colorectal Neoplasms microbiology, Dysbiosis diagnosis, Dysbiosis epidemiology, Dysbiosis microbiology, Female, Hong Kong epidemiology, Humans, Incidence, Male, Middle Aged, Retrospective Studies, Streptococcus gallolyticus isolation & purification, Streptococcus gallolyticus pathogenicity, Bacteremia microbiology, Colon microbiology, Colorectal Neoplasms blood, Dysbiosis blood, Gastrointestinal Microbiome
- Abstract
Background & Aims: Colorectal cancer (CRC) development has been associated with increased proportions of Bacteroides fragilis and certain Streptococcus, Fusobacterium, and Peptostreptococcus species in the intestinal microbiota. We investigated associations between bacteremia from specific intestinal microbes and occurrence of CRC., Methods: We performed a retrospective study after collecting data on 13,096 adult patients (exposed group) in Hong Kong hospitalized with bacteremia (identified by blood culture test) without a previous diagnosis of cancer from January 1, 2006 through December 31, 2015. We collected data on intestinal microbes previously associated with CRC (genera Bacteroides, Clostridium, Filifactor, Fusobacterium, Gemella, Granulicatella, Parvimonas, Peptostreptococcus, Prevotella, Solobacterium, and Streptococcus). Clinical information, including patient demographics, comorbid medical conditions, date of bacteremia, and bacterial species identified, were collected. The incidence of biopsy-proved CRC was compared between the exposed and unexposed (patients without bacteremia matched for age, sex, and comorbidities) groups., Results: The risk of CRC was increased in patients with bacteremia from B fragilis (hazard ratio [HR] = 3.85, 95% CI = 2.62-5.64, P = 5.5 × 10
-12 ) or Streptococcus gallolyticus (HR = 5.73, 95% CI = 2.18-15.1, P = 4.1 × 10-4 ) compared with the unexposed group. In addition, the risk of CRC was increased in patients with bacteremia from Fusobacterium nucleatum (HR = 6.89, 95% CI = 1.70-27.9, P = .007), Peptostreptococcus species (HR = 3.06, 95% CI = 1.47-6.35, P = .003), Clostridium septicum (HR = 17.1, 95% CI = 1.82-160, P = .013), Clostridium perfringens (HR = 2.29, 95% CI = 1.16-4.52, P = .017), or Gemella morbillorum (HR = 15.2, 95% CI = 1.54-150, P = .020). We observed no increased risk in patients with bacteremia caused by microbes not previously associated with colorectal neoplasms., Conclusions: In a retrospective analysis of patients hospitalized for bacteremia, we associated later diagnosis of CRC with B fragilis and S gallolyticus and other intestinal microbes. These bacteria might have entered the bloodstream from intestinal dysbiosis and perturbed barrier function. These findings support a model in which specific members of the intestinal microbiota promote colorectal carcinogenesis. Clinicians should evaluate patients with bacteremia from these species for neoplastic lesions in the colorectum., (Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.